HIF1A and Miyoshi myopathy: Although more research is needed to address this issue, the fact that metformin concentration in mitochondrial matrix can reach even 1000-fold higher values than that observed in human serum [24, 25] indicates that this drug may inhibit HIF-1 and exhibit effective anti-MM activity, even in the currently clinically applied concentrations range.